Results 11 to 20 of about 116,042 (299)
Resistance to antifungal therapies
Essays in Biochemistry, 2017 The evolution of antifungal resistance among fungal pathogens has rendered the limited arsenal of antifungal drugs futile. Considering the recent rise in the number of nosocomial fungal infections in immunocompromised patients, the emerging clinical ...
Rajendra Prasad +2 more
core +3 more sources
Candida Species Biofilms’ Antifungal Resistance [PDF]
Journal of Fungi, 2017 Candida infections (candidiasis) are the most prevalent opportunistic fungal infection on humans and, as such, a major public health problem. In recent decades, candidiasis has been associated to Candida species other than Candida albicans.
Sónia Silva +4 more
doaj +4 more sources
Antifungal resistance on Sporothrix species : an overview [PDF]
Brazilian Journal of Microbiology, 2021 Introduction The treatment of human and animal sporotrichosis is often performed with antifungal agents; however, the emergence of antifungal-resistant strains of Sporothrix species has been reported. We aimed to discuss the ability of Sporothrix species
Mezzari, Adelina +5 more
core +4 more sources
Fungal Drug Response and Antimicrobial Resistance
Journal of Fungi, 2023 Antifungal resistance is a growing concern as it poses a significant threat to public health. Fungal infections are a significant cause of morbidity and mortality, especially in immunocompromised individuals.
Paloma Osset-Trénor +2 more
doaj +1 more source
Antifungal resistance in dermatophytosis: A global health concern
Letters in Animal Biology, 2022 Dermatophytosis is a common dermatological problem in animals as well as humans which is associated with interference in immune function. Unlike the antibacterial resistance which is frequently reported, antifungal resistance is less commonly reported ...
Jubeda Begum, P Das
doaj +1 more source
Antifungal Resistance on the Rise
Journal of Investigative Dermatology, 2023 Comment on : Gupta AK, Cooper EA, Wang T, Polla Ravi S, Lincoln SA, Piguet V, McCarthy LR, Bakotic WL. Detection of Squalene Epoxidase Mutations in United States Patients with Onychomycosis: Implications for Management. J Invest Dermatol. 2023 Dec;143(12):2476-2483.e7. doi: 10.1016/j.jid.2023.04.032. Epub 2023 May 24. PMID: 37236595.
Monod, Michel +2 more
openaire +2 more sources
Antifungal resistance, combinations and pipeline: oh my!
Drugs in Context, 2023 Invasive fungal infections are a strong contributor to healthcare costs, morbidity and mortality, especially amongst hospitalized patients. Historically, Candida was responsible for approximately 15% of all nosocomial bloodstream infections.
Kayla R Stover +4 more
doaj +1 more source
Overcoming antifungal resistance [PDF]
Drug Discovery Today: Technologies, 2014 Fungal infections have become one of the major causes of morbidity and mortality in immunocompromised patients. Despite increased awareness and improved treatment strategies, the frequent development of resistance to the antifungal drugs used in clinical settings contributes to the increasing toll of mycoses.
Anand, Srinivasan +2 more
openaire +2 more sources
Antifungal resistance and clinical significance in small animals
German Journal of Veterinary Research, 2022 Fungal diseases have risen in conjunction with the increasing number of immunosuppressive diseases in human and animal populations. Despite the introduction of new antifungal agents in recent years, the incidence of fungal infections continues to ...
Yasemin Kaya +3 more
doaj +1 more source
The Microevolution of Antifungal Drug Resistance in Pathogenic Fungi
Microorganisms, 2023 The mortality rates of invasive fungal infections remain high because of the limited number of antifungal drugs available and antifungal drug resistance, which can rapidly evolve during treatment.
Kylie J. Boyce
doaj +1 more source